Navigation Links
Risk Info for Breast Cancer Patients Too Confusing
Date:12/12/2008

Could lead to bad treatment decisions, study shows

FRIDAY, Dec. 12 (HealthDay News) -- Information patients commonly receive about the risk of their breast cancer returning after surgery may make their decision on whether to get chemotherapy more difficult, a new study concludes.

Doctors typically show breast cancer patients a bar chart, based on a standard risk-assessment tool, with four different post-surgery choices: hormonal therapy alone, chemotherapy alone, hormonal therapy and chemotherapy combined, or no treatment at all. In a study, published in the December issue of Cancer, just a little more than half of 1,619 women shown the same graph correctly understood which choice would best increase their chance of survival.

"The main benefit of additional treatments such as chemotherapy after surgery is long-term risk reduction. But chemotherapy does not provide much benefit for some women, and those women can potentially avoid unnecessary side effects by skipping chemotherapy," study author Brian Zikmund-Fisher, a research assistant professor of general medicine at the University of Michigan Medical School, said in an university news release. "So understanding how large or small the risk reduction is can help women make the right choice."

The problem is there are too many choices, he said. Hormonal treatments greatly help women whose cancers are sensitive to estrogen. For these patients, the real question is whether they should add chemotherapy; but for most other patients, the choice is only chemo or no chemo.

In the study, the women -- who were given hypothetical breast cancer diagnoses -- viewed several graphics, each showing how chemotherapy would reduce the risk of dying from a return of cancer. When shown a simpler graph than showed only the two key options, rather the traditional four, 65 percent correctly found the value of chemotherapy. When the simpler graph was changed to pictograph of 100 small rectangles representing the possible outcomes, 77 percent of the women correctly reported the benefit of chemotherapy.

"Even when patients are given the information they need, they have to be able to understand it well enough to make the right choice. We're making patients work too hard. Discussions of risk need to be simple and transparent so doctors can spend as little time as possible explaining the numbers to patients and as much time as possible talking about what those numbers mean," Zikmund-Fisher said.

More information

The U.S. National Cancer Institute has more about breast cancer treatments.



-- Kevin McKeever



SOURCE: University of Michigan Comprehensive Cancer Center, news release, Dec. 8, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Survival differences by race most apparent in advanced stages of breast cancer
2. MRI finds breast cancer before it becomes dangerous
3. Pathway links inflammation, angiogenesis and breast cancer
4. Drop in breast cancer incidence linked to hormone use, not mammograms
5. Breast cancer prevention practices vary across Canada
6. Eating junk food whilst pregnant and breastfeeding may lead to obese offspring
7. Acrylamide Wont Raise Breast Cancer Risk
8. New link between estrogen and breast cancer
9. Hypnosis Eases Pain of Breast Cancer Surgery
10. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
11. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Risk Info for Breast Cancer Patients Too Confusing
(Date:3/23/2017)... ... March 23, 2017 , ... The American Board of Quality ... 40th Anniversary of ABQAURP’s dedication to Health Care Quality and Management and Patient Safety. ... not only to the association, but also to the Health Care Quality and Patient ...
(Date:3/23/2017)... ... March 23, 2017 , ... The founders of Dr. ... as winners of American Dreams & Good Housekeeping Seal Initiative, a nationwide search ... and Good Housekeeping. , Steven Wang, MD ., a renowned dermatologist and ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April 4, 2017 ... will the new EU MDR language change the way manufacturers approach CERs? ...
(Date:3/23/2017)... Rey, CA (PRWEB) , ... March 23, 2017 ... ... its customizable coding audit software solution, iCode Assurance, at HCCA’s 21st annual Compliance ... optimizes and accelerates the coding audit process for all medical chart types with ...
(Date:3/23/2017)... ... , ... “Beyond and Back”: a true-life testimony of tragedy and the miraculous ... Bonetta Rose, a wife, mother and grandmother committed to sharing her many spiritual adventures ... Rose‘s new book presents actual events in the life of her family, which validate ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) ... a Phase 1 study of MM-310 in solid tumors. ... novel taxane and targets the EphA2 receptor, a protein ... major tumor types, including prostate, ovarian, bladder, gastric, pancreatic ... study is an important step in evaluating MM-310,s safety ...
(Date:3/23/2017)... 23, 2017 /PRNewswire/ - Medicure Inc. ("Medicure" or ... pharmaceutical company, is pleased to announce that its ... from the U.S. Food and Drug Administration (FDA) ... for tetrabenazine tablets in the 12.5 mg and ... a generic equivalent of the branded product Xenazine ...
(Date:3/23/2017)... , March 23, 2017   Casetabs , the ... native mobile app for the iPhone. With this new ... coordination and communication for physician offices, ambulatory surgery centers ... app offers iPhone users even faster, more reliable access ... it even easier to connect care teams so that ...
Breaking Medicine Technology: